MWNA
TIL icon

Marshall Wace North America’s Instil Bio TIL Stock Holding History

Marshall Wace North America’s Portfolio TIL Stock Details TIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$25.9M Buy
72,293
+89
+0.1% +$33.2K 0.11% 202
2021
Q2 		$27.9M Hold
72,204
– – 0.12% 182
2021
Q1 		$36.2M Buy
+72,204
New +$37M 0.15% 160

Other funds holding TIL

VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return

Marshall Wace North America's TIL Position: Q3 2021 in Review

Marshall Wace North America increased its Instil Bio (TIL) stake by 0.12% in Q3 2021, buying an estimated $33.2K and bringing the position to 72,293 shares worth $25.9M. The position accounts for 0.11% of the portfolio, ranked #202.

Marshall Wace North America first reported a position in TIL in Q1 2021 and has held it in 3 quarters since. The position peaked at $36.2M in Q1 2021. 64 funds tracked by Wall St. Rank hold TIL as of Q3 2021.

  • Marshall Wace North America held 72,293 shares of Instil Bio worth $25.9M as of Q3 2021.
  • Marshall Wace North America bought 89 Instil Bio shares in Q3 2021, an estimated $33.2K.
  • Instil Bio made up 0.11% of Marshall Wace North America's portfolio in Q3 2021, its #202 holding.
  • Marshall Wace North America first reported a position in Instil Bio in Q1 2021 and has held it in 3 quarters since.
  • Marshall Wace North America's Instil Bio position peaked at $36.2M in Q1 2021.
  • 64 funds tracked by Wall St. Rank held Instil Bio as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.